Dan Theodorescu

30.2k total citations · 4 hit papers
335 papers, 14.6k citations indexed

About

Dan Theodorescu is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Dan Theodorescu has authored 335 papers receiving a total of 14.6k indexed citations (citations by other indexed papers that have themselves been cited), including 154 papers in Molecular Biology, 133 papers in Surgery and 107 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Dan Theodorescu's work include Bladder and Urothelial Cancer Treatments (111 papers), Prostate Cancer Diagnosis and Treatment (46 papers) and Prostate Cancer Treatment and Research (46 papers). Dan Theodorescu is often cited by papers focused on Bladder and Urothelial Cancer Treatments (111 papers), Prostate Cancer Diagnosis and Treatment (46 papers) and Prostate Cancer Treatment and Research (46 papers). Dan Theodorescu collaborates with scholars based in United States, Canada and Germany. Dan Theodorescu's co-authors include Henry F. Frierson, Steven C. Smith, Michael A. Harding, Mark R. Conaway, Charles R. Owens, Jason E. Duex, Gary Oxford, Garret M. Hampton, Garrett M. Dancik and Patricia S. Steeg and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Dan Theodorescu

325 papers receiving 14.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The multiMiR R package and database: integration of microRNA–target interactions along with their disease and drug associations

2014 475 citations Yuanbin Ru, Dan Theodorescu et al. profile →
Advances in bladder cancer biology and therapy

2020 456 citations Neeraj Agarwal, Jason E. Duex et al. profile →
Bladder cancer

2023 212 citations Donna E. Hansel, Dan Theodorescu et al. profile →
Y chromosome loss in cancer drives growth by evasion of adaptive immunity

2023 94 citations Dan Theodorescu et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Dan Theodorescu	7.5k	3.8k	3.6k	3.1k	2.8k	335	14.6k
Jack A. Schalken	9.6k 1.3×	3.0k 0.8×	3.4k 1.0×	8.9k 2.9×	5.1k 1.8×	410	19.6k
Norio Nonomura	4.6k 0.6×	2.3k 0.6×	2.4k 0.7×	3.6k 1.1×	1.8k 0.7×	598	11.4k
Helmut Klocker	6.9k 0.9×	1.0k 0.3×	3.0k 0.8×	6.6k 2.1×	3.1k 1.1×	364	15.1k
Christopher J. Logothetis	6.9k 0.9×	3.9k 1.0×	7.9k 2.2×	9.6k 3.1×	3.7k 1.3×	458	20.8k
John T. Isaacs	10.9k 1.5×	1.3k 0.4×	5.4k 1.5×	8.3k 2.7×	3.6k 1.3×	311	21.3k
Glen Kristiansen	12.2k 1.6×	2.8k 0.7×	6.5k 1.8×	5.5k 1.8×	6.5k 2.3×	540	22.1k
Joel S. Greenberger	7.7k 1.0×	3.0k 0.8×	3.1k 0.9×	3.2k 1.0×	1.7k 0.6×	447	18.6k
Hideaki Miyake	4.0k 0.5×	2.7k 0.7×	3.2k 0.9×	4.7k 1.5×	2.1k 0.8×	620	10.8k
Jiaoti Huang	7.3k 1.0×	1.4k 0.4×	4.3k 1.2×	8.2k 2.6×	3.8k 1.4×	308	16.4k
Arndt Hartmann	8.7k 1.2×	6.4k 1.7×	6.0k 1.7×	4.9k 1.6×	4.5k 1.6×	715	21.0k

Countries citing papers authored by Dan Theodorescu

Since Specialization

Citations

This map shows the geographic impact of Dan Theodorescu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Theodorescu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Theodorescu more than expected).

Fields of papers citing papers by Dan Theodorescu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan Theodorescu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Theodorescu. The network helps show where Dan Theodorescu may publish in the future.

Co-authorship network of co-authors of Dan Theodorescu

This figure shows the co-authorship network connecting the top 25 collaborators of Dan Theodorescu. A scholar is included among the top collaborators of Dan Theodorescu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan Theodorescu. Dan Theodorescu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sottnik, Joseph L., Lauren A. Vanderlinden, Molishree Joshi, et al.. (2021). Androgen Receptor Regulates CD44 Expression in Bladder Cancer. Cancer Research. 81(11). 2833–2846. 32 indexed citations

Flaig, Thomas W., Catherine M. Tangen, Siamak Daneshmand, et al.. (2021). A Randomized Phase II Study of Coexpression Extrapolation (COXEN) with Neoadjuvant Chemotherapy for Bladder Cancer (SWOG S1314; NCT02177695). Clinical Cancer Research. 27(9). 2435–2441. 58 indexed citations

Duex, Jason E., Charles R. Owens, Garrett M. Dancik, et al.. (2017). Nuclear CD24 Drives Tumor Growth and Is Predictive of Poor Patient Prognosis. Cancer Research. 77(18). 4858–4867. 22 indexed citations

Agarwal, Neeraj, Garrett M. Dancik, Andrew Goodspeed, et al.. (2016). GON4L Drives Cancer Growth through a YY1–Androgen Receptor–CD24 Axis. Cancer Research. 76(17). 5175–5185. 42 indexed citations

Hensel, Jonathan A., Jason E. Duex, Charles R. Owens, et al.. (2015). Patient Mutation Directed shRNA Screen Uncovers Novel Bladder Tumor Growth Suppressors. Molecular Cancer Research. 13(9). 1306–1315. 25 indexed citations

Guin, Sunny, Yuanbin Ru, Neeraj Agarwal, et al.. (2015). Loss of Glycogen Debranching Enzyme AGL Drives Bladder Tumor Growth via Induction of Hyaluronic Acid Synthesis. Clinical Cancer Research. 22(5). 1274–1283. 24 indexed citations

Gustafson, Daniel L., Jared S. Fowles, Kristen C. Brown, & Dan Theodorescu. (2015). Drug Selection in the Genomic Age: Application of the Coexpression Extrapolation Principle for Drug Repositioning in Cancer Therapy. Assay and Drug Development Technologies. 13(10). 623–627. 4 indexed citations

Nickerson, Michael L., Garrett M. Dancik, Kate M. Im, et al.. (2014). Concurrent Alterations in TERT , KDM6A , and the BRCA Pathway in Bladder Cancer. Clinical Cancer Research. 20(18). 4935–4948. 87 indexed citations

Griner, Erin, Garrett M. Dancik, James C. Costello, et al.. (2014). RhoC Is an Unexpected Target of RhoGDI2 in Prevention of Lung Colonization of Bladder Cancer. Molecular Cancer Research. 13(3). 483–492. 15 indexed citations

10.

Wang, Hong, Yuanbin Ru, Marta Sänchez‐Carbayo, et al.. (2013). Translation Initiation Factor eIF3b Expression in Human Cancer and Its Role in Tumor Growth and Lung Colonization. Clinical Cancer Research. 19(11). 2850–2860. 68 indexed citations

11.

Smith, Steven C., Alexander S. Baras, Charles R. Owens, Garrett M. Dancik, & Dan Theodorescu. (2012). Transcriptional Signatures of Ral GTPase Are Associated with Aggressive Clinicopathologic Characteristics in Human Cancer. Cancer Research. 72(14). 3480–3491. 33 indexed citations

12.

Thomas, Shibu, Michael A. Harding, Steven C. Smith, et al.. (2012). CD24 Is an Effector of HIF-1–Driven Primary Tumor Growth and Metastasis. Cancer Research. 72(21). 5600–5612. 117 indexed citations

13.

Overdevest, Jonathan B., Shibu Thomas, Glen Kristiansen, et al.. (2011). CD24 Offers a Therapeutic Target for Control of Bladder Cancer Metastasis Based on a Requirement for Lung Colonization. Cancer Research. 71(11). 3802–3811. 97 indexed citations

14.

Dancik, Garrett M., Yuanbin Ru, Charles R. Owens, & Dan Theodorescu. (2011). A Framework to Select Clinically Relevant Cancer Cell Lines for Investigation by Establishing Their Molecular Similarity with Primary Human Cancers. Cancer Research. 71(24). 7398–7409. 21 indexed citations

15.

Thomas, Shibu, Jonathan B. Overdevest, Matthew D. Nitz, et al.. (2010). Src and Caveolin-1 Reciprocally Regulate Metastasis via a Common Downstream Signaling Pathway in Bladder Cancer. Cancer Research. 71(3). 832–841. 79 indexed citations

16.

Lee, Jae K., Charles Coutant, Young Chul Kim, et al.. (2010). Prospective Comparison of Clinical and Genomic Multivariate Predictors of Response to Neoadjuvant Chemotherapy in Breast Cancer. Clinical Cancer Research. 16(2). 711–718. 60 indexed citations

17.

Wang, Hong, et al.. (2010). Phosphorylation of RalB Is Important for Bladder Cancer Cell Growth and Metastasis. Cancer Research. 70(21). 8760–8769. 48 indexed citations

18.

Schiffer, Eric, Antonia Vlahou, Andreas Petrolekas, et al.. (2009). Prediction of Muscle-invasive Bladder Cancer Using Urinary Proteomics. Clinical Cancer Research. 15(15). 4935–4943. 82 indexed citations

19.

Wu, Yimin, Konstadinos Moissoglu, Hong Wang, et al.. (2009). Src phosphorylation of RhoGDI2 regulates its metastasis suppressor function. Proceedings of the National Academy of Sciences. 106(14). 5807–5812. 61 indexed citations

20.

Moissoglu, Konstadinos, et al.. (2009). Rho GDP Dissociation Inhibitor 2 Suppresses Metastasis via Unconventional Regulation of RhoGTPases. Cancer Research. 69(7). 2838–2844. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact